PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Ciprofol Matches Propofol for Extubation Time in Pediatric Laparoscopic TIVA

ciprofolpropofoltotal intravenous anesthesiaTIVAGABA-A agonistpediatric anesthesialaparoscopic surgeryrandomized controlled trialnon-inferiorityextubation timeemergence deliriumoff-label pediatric usehemodynamics Pediatrics

Background Information

Ciprofol shows promise as an alternative to propofol for pediatric anesthesia.

This study investigates ciprofol as an alternative to propofol for pediatric anesthesia, focusing on safety and extubation time. Ciprofol was non-inferior to propofol with shorter extubation time (17.3 vs 20.1 minutes), and comparable safety profiles. While ciprofol shows promise as a non-inferior alternative to propofol in children, further studies are needed to establish safety and efficacy completely. Ciprofol may be a viable alternative to propofol for pediatric anesthesia, pending further research.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Xu L, Pan R, Dai X, Xu A

Citation: Xu L, Pan R, Dai X, et al. Ciprofol-Based Total Intravenous Anesthesia During Pediatric Laparoscopic Surgery: A Double-Blind, Randomized Controlled, Non-Inferiority Clinical Trial. Drug design, development and therapy. 2026;20:657125. doi:10.2147/DDDT.S657125

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.